New Enterprise Associates 12, Limited Partnership
CIK 1383391 · last filed 2020-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$699.04M
Companies
12
Total Filings
30
Lifetime Open-Market Net
-$299.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARDX | 10%+ Owner | 8,086,401 | $4.00 | $32.35M | $95.00M | 5 | 2020-06-12 |
| Tintri, Inc. (TNTR) Delisted | 10%+ Owner | 2,724,795 | — | — | $6.49M | 1 | 2017-07-10 |
| Zosano Pharma Corp (ZSAN) Delisted | 10%+ Owner | 3,029 | $0.56 | $1.7K | -$11.6K | 1 | 2016-08-26 |
| TREVENA INC (TRVN) Delisted | 10%+ Owner | 7,699 | $0.01 | $85 | $40.00M | 1 | 2014-12-10 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 1,331,238 | $18.62 | $24.79M | -$8.51M | 1 | 2014-08-29 |
| CHANNELADVISOR CORP (ECOM) Delisted | 10%+ Owner | 1,661,357 | $23.09 | $38.36M | -$321.70M | 1 | 2013-11-13 |
| GRPN | 10%+ Owner | 2,709,248 | $25.03 | $67.81M | $0 | 2 | 2013-09-17 |
| WDAY | 10%+ Owner | 2,321,212 | $179.64 | $416.98M | $0 | 1 | 2013-04-11 |
| FUSION-IO, INC. (FIO) Delisted | 10%+ Owner | 9,058,379 | — | — | -$122.74M | 14 | 2012-09-06 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | 10%+ Owner | 2,206,740 | — | — | $15.00M | 1 | 2012-08-02 |
| ECHO | 10%+ Owner | 2,020,219 | $90.04 | $181.90M | $0 | 1 | 2012-03-01 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | 10%+ Owner | 0 | — | — | -$3.26M | 1 | 2011-03-14 |
Recent Filings · Page 3 of 3
30 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-02-27 | FUSION-IO, INC. (FIO) Delisted | Other (J) | −2,000,000 | $0 | EDGAR |
| 2012-02-23 | FUSION-IO, INC. (FIO) Delisted | Other (J) | −1,000,000 | $0 | EDGAR |
| 2012-02-16 | FUSION-IO, INC. (FIO) Delisted | Other (J) | −1,000,000 | $0 | EDGAR |
| 2012-02-16 | FUSION-IO, INC. (FIO) Delisted | Other (J) | −1,000,000 | $0 | EDGAR |
| 2012-02-14 | FUSION-IO, INC. (FIO) Delisted | Other (J) | −1,000,000 | $0 | EDGAR |
| 2012-02-09 | FUSION-IO, INC. (FIO) Delisted | Other (J) | −1,000,000 | $0 | EDGAR |
| 2012-02-06 | FUSION-IO, INC. (FIO) Delisted | Other (J) | −1,980,000 | $0 | EDGAR |
| 2011-12-28 | FUSION-IO, INC. (FIO) Delisted | Other (J) | −2,970,000 | $0 | EDGAR |
| 2011-11-30 | FUSION-IO, INC. (FIO) Delisted | Sell (S) | −3,874,479 | -$122.74M | EDGAR |
| 2011-03-14 | ARYx Therapeutics, Inc. (ARYX) Delisted | Sell (S) | −44,692,740 | -$3.26M | EDGAR |
Showing 21–30 of 30
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.